INTEGRATED BIOPHARMA INC (INBP) › Shareholders' EquityINTEGRATED BIOPHARMA INC (INBP) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: -$5.70M2011: -$7.70M2012: -$10.38M2013: -$10.29M2014: -$10.15M2015: -$9.32M2016: -$8.33M2017: -$5.93M2018: -$5.24M2019: $1.89M2020: $6.07M2021: $14.33M2022: $18.57M2023: $18.86M2024: $19.24M2025: $20.32M$20.32M2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$20.32M+5.6%2024$19.24M+2.0%2023$18.86M+1.5%2022$18.57M+29.6%2021$14.33M+136.3%2020$6.07M+220.5%2019$1.89M+136.2%2018-$5.24M+11.7%2017-$5.93M+28.8%2016-$8.33M+10.6%2015-$9.32M+8.3%2014-$10.15M+1.3%2013-$10.29M+0.9%2012-$10.38M-34.9%2011-$7.70M-35.1%2010-$5.70M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share